Chinese Journal of Tissue Engineering Research

Previous Articles     Next Articles

Construction and Identification of pIRES2-BDNF-VEGF165 bicistronic eukaryotic expression vector

Li Bing-nan, Li Wei-dong, Lin Jun-tang, Feng Hui-gen   

  1. Department of Life Sciences and Technology, Xinxiang Medical University, Xinxiang 453003, Henan Province, China
  • Revised:2013-09-06 Online:2013-12-10 Published:2013-12-10
  • Contact: Li Bing-nan, Department of Life Sciences and Technology, Xinxiang Medical University, Xinxiang 453003, Henan Province, China bingnanli120@yeah.net
  • About author:Li Bing-nan☆, Ph.D., Lecturer, Department of Life Sciences and Technology, Xinxiang Medical University, Xinxiang 453003, Henan Province, China bingnanli120@yeah.net Li Wei-dong, Studying for master’s degree, Department of Life Sciences and Technology, Xinxiang Medical University, Xinxiang 453003, Henan Province, China
  • Supported by:

    the Tender Subject of Key Research Areas of Xinxiang Medical Uuniversity in 2011, No. ZD2011-16*; Key Projects in Scientific Research of Henan Provincial Education Department, No. 13A180850*

Abstract:

BACKGROUND: Brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor 165 (VEGF165) are essential genes for cell differentiation. Virus mediated method has been used numerously in researches, but the security is the most important problem. Eukaryotic expressing vector is a way to solve this question.
OBJECTIVE: To construct and identify pIRES2-BDNF-VEGF165 bicistronic eukaryotic expression vector.
METHODS: BDNF genes were obtained from the genomic DNA of human peripheral blood mononuclear cells by PCR. Then, the BDNF cDNA fragment was inserted into the multiple cloning sites of pIRES2-EGFP to generate the bicistronic eukaryotic expression plasmid pIRES2-BDNF-EGFP. The VEGF165 gene was obtained from pIRES2-VEGF165-EGFP plasmid by double PCR. Next step was that VEGF165 cDNA fragment was cloned into the pIRES2BDNF-EGFP instead of EGFP to create a double gene co -expressing vector plasmid pIRES2-BDNF-VEGF165. Then, pIRES2-BDNF-VEGF165 was used to transfect HEK293 cells, and RT-PCR and western-blot assay were employed to test the co-expression of double genes.
RESULTS AND CONCLUSION: BDNF and VEGF165 genes were cloned in this study. The DNA sequencing analysis demonstrated that the BDNF and VEGF165 were exactly consistent with the sequence recorded in the GenBank. The size of BDNF gene was 744 bp. The VEGF165 gene was obtained from pIRES2-VEGF165-EGFP plasmid by PCR, and the size of VEGF165 gene was 576 bp. Enzyme digestion analysis indicated that BDNF and VEGF165 genes were inserted into the expression vector pIRES2-EGFP correctly and the BDNF and VEGF165 co-expression plasmid was successfully constructed. Then, by transfecting pIRES2-BDNF-VEGF165 into HEK293 cells, double genes were expressed at the mRNA and protein level. It provides a novel expression system, which enables further study on the functions of BDNF and VEGF165 genes.



中国组织工程研究
杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松组织工程


全文链接:

Key words: brain-derived neurotrophic factor, vascular endothelial growth factors, ribosomes, transfection, eukaryotic cells

CLC Number: